Inhibitory effect of methyleugenol on IgE-mediated allergic inflammation in RBL-2H3 cells

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Tang, Feng ^a   Chen, Feilong ^a   Ling, Xiao ^a   Huang, Yao ^a   Zheng, Xiaomei ^a   Tang, Qingfa ^a   Tan, Xiaomei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BETA N ACETYLHEXOSAMINIDASE; FC RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 4; LEUKOTRIENE B4; LEUKOTRIENE C4; METHYLEUGENOL; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROTEIN KINASE SYK; TUMOR NECROSIS FACTOR ALPHA; EUGENOL; MITOGEN ACTIVATED PROTEIN KINASE; MUTAGENIC AGENT; TUMOR NECROSIS FACTOR;

ALLERGIC REACTION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; INFLAMMATION; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; CELL RESPIRATION; CHEMISTRY; CYTOLOGY; ENZYME IMMUNOASSAY; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; RAT; TUMOR CELL LINE;

ANIMALS; ARACHIDONIC ACID; BETA-N-ACETYLHEXOSAMINIDASES; CELL LINE, TUMOR; CELL RESPIRATION; DINOPROSTONE; EUGENOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYPERSENSITIVITY; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-4; LEUKOTRIENE B4; LEUKOTRIENE C4; MAST CELLS; MUTAGENS; PROSTAGLANDIN D2; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928777495     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/463530     Document Type: Article

References (32)

1. C. Flohr, R. J. Quinnell, and J. Britton, "Do helminth parasites protect against atopy and allergic disease?" Clinical and Experimental Allergy, vol. 39, no. 1, pp. 20-32, 2009.
2. K. J. Erb, "Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?" Trends in Immunology, vol. 30, no. 2, pp. 75-82, 2009.
3. B. S. Bochner and R. P. Schleimer, "Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment," Immunological Reviews, vol. 179, pp. 5-15, 2001.
4. S. J. Galli, "New concepts about the mast cell," The New England Journal of Medicine, vol. 328, no. 4, pp. 257-265, 1993.
5. M. Nguyen, A. J. Pace, and B. H. Koller, "Age-induced reprogramming of mast cell degranulation," Journal of Immunology, vol. 175, no. 9, pp. 5701-5707, 2005.
6. A.M. Gilfillan and C. Tkaczyk, "Integrated signalling pathways formast-cell activation," Nature Reviews Immunology, vol. 6, no. 3, pp. 218-230, 2006.
7. M. K. Church and F. Levi-Schaffer, "The human mast cell," Journal of Allergy and Clinical Immunology, vol. 99, no. 2, pp. 155-160, 1997.
8. D. D. Metcalfe, M. Kaliner, and M. A. Donlon, "The mast cell," Critical Reviews in Immunology, vol. 3, no. 1, pp. 23-74, 1981.
9. W. Duan and W. S. F. Wong, "Targeting mitogen-activated protein kinases for asthma," Current Drug Targets, vol. 7, no. 6, pp. 691-698, 2006.
10. A. Lorentz, I. Klopp, T. Gebhardt, M. P. Manns, and S. C. Bischoff, "Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells," Journal of Allergy and Clinical Immunology, vol. 111, no. 5, pp. 1062-1068, 2003.
11. B. Frossi, J. Rivera, E. Hirsch, and C. Pucillo, "Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition," The Journal of Immunology, vol. 178, no. 4, pp. 2549-2555, 2007.
12. Y. Kawakami, S. E. Hartman, P. M. Holland, J. A. Cooper, and T. Kawakami, "Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7," Journal of Immunology, vol. 161, no. 4, pp. 1795-1802, 1998.
13. D. Hata, Y. Kawakami, N. Inagaki et al., "Involvement of Bruton's tyrosine kinase in Fcepsilon RI-dependent mast cell degranulation and cytokine production," Journal of Experimental Medicine, vol. 187, no. 8, pp. 1235-1247, 1998.
14. S. Yano, Y. Suzuki, M. Yuzurihara et al., "Antinociceptive effect of methyleugenol on formalin-induced hyperalgesia in mice," European Journal of Pharmacology, vol. 553, no. 1-3, pp. 99-103, 2006.
15. K. Hashimoto, T. Yanagisawa, Y. Okui, Y. Ikeya, M. Maruno, and T. Fujita, "Studies on anti-allergic components in the roots of Asiasarum sieboldi," Planta Medica, vol. 60, no. 2, pp. 124-127, 1994.
16. C. C. Lima, D. N. Criddle, A. N. Coelho-De-Souza, F. J. Q. Monte, M. Jaffar, and J. H. Leal-Cardoso, "Relaxant and antispasmodic actions of methyleugenol on guinea-pig isolated ileum," Planta Medica, vol. 66, no. 5, pp. 408-411, 2000.
17. Y. K. Choi, G.-S. Cho, S. Hwang et al., "Methyleugenol reduces cerebral ischemic injury by suppression of oxidative injury and inflammation," Free Radical Research, vol. 44, no. 8, pp.925-935, 2010.
18. B. K. Shin, E. H. Lee, and H. M. Kim, "Suppression of Lhistidine decarboxylase mRNA expression by methyleugenol," Biochemical and Biophysical Research Communications, vol. 232, no. 1, pp. 188-191, 1997.
19. M. Ishiyama, H. Tominaga, M. Shiga, K. Sasamoto, Y. Ohkura, and K. Ueno, "A combined assay of cell viability and in vitro cytotoxicity with a highlywater-soluble tetrazoliumsalt, neutral red and crystal violet," Biological and Pharmaceutical Bulletin, vol. 19, no. 11, pp. 1518-1520, 1996.
20. M. Arima and T. Fukuda, "Prostaglandin D2 and TH2 inflammation in the pathogenesis of bronchial asthma," The Korean Journal of Internal Medicine, vol. 26, no. 1, pp. 8-18, 2011.
21. E. Nettis, M. D'Erasmo, E. di Leo et al., "The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field," Mediators of Inflammation, vol. 2010, Article ID 628171, 6 pages, 2010.
22. Y. Kawakami, J. Kitaura, A. B. Satterthwaite et al., "Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation," Journal of Immunology, vol. 165, no. 3, pp. 1210-1219, 2000.
23. K. Roth, W. M. Chen, and T. J. Lin, "Positive and negative regulatory mechanisms in high-affinity IgE receptor-mediated mast cell activation," Archivum Immunologiae et Therapiae Experimentalis, vol. 56, no. 6, pp. 385-399, 2008.
24. Y. Kim, Y.-S. Lee, J.-H. Hahn et al., "Hyaluronic acid targets CD44 and inhibits Fc∈RI signaling involving PKCδ, Rac1, ROS, and MAPK to exert anti-allergic effect," Molecular Immunology, vol. 45, no. 9, pp. 2537-2547, 2008.
25. Y. S. Wang, Pharmacology and Application of Chinese Materia Medica, People's Health Publisher, Beijing, China, 1983.
26. R. H. Zhou, Resource Science of Chinese Medicinal Materials, China Medical & Pharmaceutical Sciences Press, Beijing, China, 1993.
27. T. C. Theoharides and D. Kalogeromitros, "The critical role of mast cells in allergy and inflammation," Annals of the New York Academy of Sciences, vol. 1088, pp. 78-99, 2006.
28. Y. Nabeshima, T. Hiragun, E. Morita, S. Mihara, Y. Kameyoshi, and M. Hide, "IL-4 modulates the histamine content of mast cells in a mast cell/fibroblast co-culture through a Stat6 signaling pathway in fibroblasts," FEBS Letters, vol. 579, no. 29, pp. 6653-6658, 2005.
29. J.-L. Boulay and W. E. Paul, "The interleukin-4 family of lymphokines," Current Opinion in Immunology, vol. 4, no. 3, pp. 294-298, 1992.
30. A. W. Ford-Hutchinson, M. A. Bray, M. V. Doig, M. E. Shipley, and M. J. H. Smith, "Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes," Nature, vol. 286, no. 5770, pp. 264-265, 1980.
31. A. M. Tager and A. D. Luster, "BLT1 and BLT2: the leukotriene B(4) receptors," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 69, no. 2-3, pp. 123-134, 2003.
32. T. C. T. M. van der Pouw Kraan, L. C. M. Boeije, R. J. T. Smeenk, J. Wijdenes, and L. A. Aarden, "Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production," Journal of Experimental Medicine, vol. 181, no. 2, pp. 775-779, 1995.